Livogrit Mitigates ANIT-Induced Cholestasis-Like Symptoms in an In Vivo model by Curbing Hepatic Inflammation and Regulating BAX, TGF-β, MMP-9 and α-SMA Gene Expression

Authors

Acharya Balkrishna

Published

January 1, 2025

Add a comment...

Supporters

Support the authors with ResearchCoin

Journal

Heliyon

Topics

DOI

10.1016/j.heliyon.2025.e41855

License

CC-BY

Livogrit Mitigates ANIT-Induced Cholestasis-Like Symptoms in an In Vivo model by Curbing Hepatic Inflammation and Regulating BAX, TGF-β, MMP-9 and α-SMA Gene Expression

Authors

Acharya Balkrishna

Published

January 1, 2025

Add a comment...

Supporters

Support the authors with ResearchCoin

Journal

Heliyon

Topics

DOI

10.1016/j.heliyon.2025.e41855

License

CC-BY

Paper

Paper

Paper

Paper

Livogrit Mitigates ANIT-Induced Cholestasis-Like Symptoms in an In Vivo model by Curbing Hepatic Inflammation and Regulating BAX, TGF-β, MMP-9 and α-SMA Gene Expression

Supporters

Journal

Topics

DOI

License

Livogrit Mitigates ANIT-Induced Cholestasis-Like Symptoms in an In Vivo model by Curbing Hepatic Inflammation and Regulating BAX, TGF-β, MMP-9 and α-SMA Gene Expression

Supporters

Journal

Topics

DOI

License

Supporters

Journal

Topics

DOI

License